145 related articles for article (PubMed ID: 26410037)
1. Association of androgen receptor CAG repeat polymorphism and risk of epithelial ovarian cancer.
Zhu T; Yuan J; Xie Y; Li H; Wang Y
Gene; 2016 Jan; 575(2 Pt 3):743-6. PubMed ID: 26410037
[TBL] [Abstract][Full Text] [Related]
2. The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer.
Meng X; Lu P; Chu Z; Fan Q
Oncotarget; 2016 Jan; 7(2):2105-12. PubMed ID: 26556855
[TBL] [Abstract][Full Text] [Related]
3. CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.
Kim SC; Ju W; Mahavni V; Geisler JP; Buller RE
Int J Gynecol Cancer; 2006; 16 Suppl 1():190-4. PubMed ID: 16515589
[TBL] [Abstract][Full Text] [Related]
4. Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case-control study.
Li K; Zhong C; Wang J; Wang B; He J; Bi J
Tumour Biol; 2014 Dec; 35(12):12519-23. PubMed ID: 25217983
[TBL] [Abstract][Full Text] [Related]
5. Associations between androgen receptor CAG & GGN repeat polymorphism & recurrent spontaneous abortions in Chinese women.
Chuan Z; Jie D; Hao X; Junhua B; Mengjing G; Liguo P; Yousheng Y; Hong L; Zhenghao H
Indian J Med Res; 2014 May; 139(5):730-6. PubMed ID: 25027083
[TBL] [Abstract][Full Text] [Related]
6. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.
Schildkraut JM; Murphy SK; Palmieri RT; Iversen E; Moorman PG; Huang Z; Halabi S; Calingaert B; Gusberg A; Marks JR; Berchuck A
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):473-80. PubMed ID: 17372242
[TBL] [Abstract][Full Text] [Related]
7. The AIB1 gene polyglutamine repeat length polymorphism contributes to risk of epithelial ovarian cancer risk: a case-control study.
Han G; Xie S; Fang H; Li G; Han Y; Qin Z
Tumour Biol; 2015 Jan; 36(1):371-4. PubMed ID: 25263716
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor gene CAG repeat polymorphism and ovarian cancer risk: A meta-analysis.
Deng Y; Wang J; Wang L; Du Y
Biosci Trends; 2017 May; 11(2):193-201. PubMed ID: 28250337
[TBL] [Abstract][Full Text] [Related]
9. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.
Li AJ; Baldwin RL; Karlan BY
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3667-73. PubMed ID: 14506156
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
Li AJ; Scoles DR; Armstrong KU; Karlan BY
Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.
Terry KL; De Vivo I; Titus-Ernstoff L; Shih MC; Cramer DW
Cancer Res; 2005 Jul; 65(13):5974-81. PubMed ID: 15994977
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.
Elattar A; Warburton KG; Mukhopadhyay A; Freer RM; Shaheen F; Cross P; Plummer ER; Robson CN; Edmondson RJ
Gynecol Oncol; 2012 Jan; 124(1):142-7. PubMed ID: 22001143
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor CAG repeat length is associated with ovarian reserve but not with ovarian response.
Lledó B; Llácer J; Turienzo A; Ortiz JA; Guerrero J; Morales R; Ten J; Bernabeu R
Reprod Biomed Online; 2014 Oct; 29(4):509-15. PubMed ID: 25131556
[TBL] [Abstract][Full Text] [Related]
14. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
[TBL] [Abstract][Full Text] [Related]
15. Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility.
Huo ZH; Zhong HJ; Zhu YS; Xing B; Tang H
Genet Mol Res; 2013 Mar; 12(3):3435-43. PubMed ID: 23546975
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor (CAG)n polymorphisms and breast cancer risk in a Han Chinese population.
Dang J; Peng L; Zhong HJ; Huo ZH
Genet Mol Res; 2015 Aug; 14(3):10258-66. PubMed ID: 26345963
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
[TBL] [Abstract][Full Text] [Related]
18. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
19. Relationships among androgen receptor CAG repeat polymorphism, sex hormones and penile length in Han adult men from China: a cross-sectional study.
Ma YM; Wu KJ; Ning L; Zeng J; Kou B; Xie HJ; Ma ZK; Wang XY; Gong YG; He DL
Asian J Androl; 2014; 16(3):478-81. PubMed ID: 24589466
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
